Roger Toothaker holds a PhD in Pharmaceutics from UW-Madison, and has been directly involved in drug development for over 40 years. His career has focused primarily on relationships between pharmacokinetics and drug effect in both nonclinical and clinical settings. Now, as an independent drug development consultant, he champions the use of model-based drug development through appropriate pharmacokinetic and pharmacodynamic measurements, modeling/simulation, and promoting continual learning to understand the true value of potential new therapeutics under a unique business model emphasizing the value of translational clinical research.
PKPD Strategies works with you to help you identify appropriate model-informed drug development strategies on which to base pipeline, design, and regulatory decisions.
Establish Basis for Clinical Development at Pre-clinical Development Stage
Use Established Basis to Facilitate Clinical Development Strategy